Nature's Sunshine (NATR) Officer Reduces Stake to 50,051 Shares

Rhea-AI Filing Summary

Jonathan D. Lanoy, SVP and Chief Accounting Officer of Nature's Sunshine Products, sold 5,000 common shares on 08/13/2025 at $16.51 per share. After the transaction he beneficially owned 50,051 shares. The Form 4 was signed by an attorney-in-fact on 08/15/2025 and identifies the filing as a single reporting person submission.

Insights

Financial Analyst

TL;DR: Insider sale of 5,000 shares reduces holdings to 50,051; transaction appears routine and limited in size.

The filing discloses a non-derivative sale of 5,000 common shares at $16.51, leaving the reporting officer with 50,051 shares. For most investors this size of sale is unlikely to materially change ownership percentages or company valuation. The disclosure is timely and follows Section 16 reporting requirements; no additional compensatory or derivative transactions are reported.

Corporate Governance Expert

TL;DR: Officer disclosed sale complies with Form 4 rules; no red flags from filing alone.

The Form 4 shows the reporting person is an officer (SVP, Chief Accounting Officer) and that the transaction was reported promptly. The form was executed by an attorney-in-fact, which is acceptable when properly authorized. There is no indication of a Rule 10b5-1 plan or other planned-trade notation on the face of this filing.

Insider Trade Summary

Net Seller: 5,000 shares ($82,550)

Net Sell 1 txn

Insider Lanoy Jonathan David

Role SVP, Chief Accounting Officer

Sold 5,000 shs ($83K)

Type	Security	Shares	Price	Value
Sale	Common Shares	5,000	$16.51	$83K

Holdings After Transaction: Common Shares — 50,051 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lanoy Jonathan David

(Last) (First) (Middle)

2901 W. BLUEGRASS BLVD.

STE 500

(Street)

LEHI UT 84043

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATURES SUNSHINE PRODUCTS INC [ NATR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/13/2025		S		5,000	D	$16.51	50,051	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Nathan G. Brower as attorney-in-fact for Jonathan D. Lanoy	08/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Jonathan D. Lanoy report on the Form 4 for NATR?

The Form 4 reports a sale of 5,000 common shares on 08/13/2025 at a price of $16.51 per share.

How many NATR shares does the reporting person own after the reported sale?

After the sale the reporting person beneficially owned 50,051 shares.

What is the reporting person's role at Nature's Sunshine Products (NATR)?

The reporting person is identified as an Officer with the title SVP, Chief Accounting Officer.

When was the Form 4 filed or signed for this transaction?

The signature block shows the form was signed by an attorney-in-fact on 08/15/2025 reflecting the reported 08/13/2025 transaction date.

Does the Form 4 indicate any derivative or compensatory transactions?

No. The Form 4 lists only a non-derivative common share sale and contains no entries in the derivative/compensatory sections.